The impact of high-dose glucocorticoids on the outcome of immune checkpoint inhibitor–related thyroid disorders

Thyroid disorders have emerged as one of the most common immune-related adverse events (irAEs), yet optimum management and biomarkers to predict vulnerable individuals remain to be explored. High-dose glucocorticoid (HDG) therapy is routinely recommended for irAEs. However, systematic analysis of th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Immunol Res
Autors principals: Ma, Chanjuan, Hodi, F. Stephen, Giobbie-Hurder, Anita, Wang, Xiaocheng, Zhou, Jing, Zhang, Amy, Zhou, Ying, Mao, Fei, Angell, Trevor E., Andrews, Chelsea P., Hu, Jiani, Barroso-Sousa, Romualdo, Kaiser, Ursula B., Tolaney, Sara M., Min, Le
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6606328/
https://ncbi.nlm.nih.gov/pubmed/31088848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-18-0613
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars